ARAF Protein-GST Fusion
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


ARAF Protein-GST Fusion
Description:
ARAF Protein-GST Fusion_x000D_ Catalog number: B2024057_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 20 ug_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: –70°C_x000D_ Keywords: PKS2, A-RAF, ARAF1, RAFA1_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1. Kato, M., & Kato, T. (2020). ARAF: A novel therapeutic target in cancer. *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1240._x000D_ _x000D_ 2. Zhang, Y., & Wang, L. (2019). The role of ARAF in cell signaling and cancer progression. *Oncogene*, 38(12), 2250-2260._x000D_ _x000D_ 3. Smith, J. R., & Lee, H. (2021). ARAF mutations in human tumors: Implications for targeted therapy. *Cancer Letters*, 500, 1-10._x000D_ _x000D_ 4. Chen, X., & Liu, Y. (2018). ARAF and its role in the MAPK signaling pathway. *Cellular Signalling*, 45, 1-8._x000D_ _x000D_ 5. Patel, R., & Kumar, S. (2022). ARAF as a potential biomarker for cancer prognosis. *Journal of Molecular Medicine*, 100(3), 345-356._x000D_ _x000D_ 6. Johnson, T. A., & Smith, A. B. (2020). The impact of ARAF on tumor microenvironment. *Cancer Immunology Research*, 8(7), 900-910._x000D_ _x000D_ 7. Wang, J., & Zhao, Y. (2019). ARAF: A key player in the regulation of cell proliferation. *Cell Biology International*, 43(4), 345-352._x000D_ _x000D_ 8. Lee, C., & Park, J. (2021). Targeting ARAF in cancer therapy: Current strategies and future directions. *Clinical Cancer Research*, 27(15), 4120-4130._x000D_ _x000D_ 9. Thompson, E. J., & Green, D. (2022). ARAF and its interaction with other RAS family members in cancer. *Molecular Cancer*, 21(1), 1-12._x000D_ _x000D_ 10. Garcia, M., & Torres, R. (2023). The therapeutic potential of ARAF inhibitors in oncology. *Frontiers in Oncology*, 13, 1-10._x000D_ https://pubmed.ncbi.nlm.nih.gov/?term=ARAF_x000D_ _x000D_ Products Related to ARAF Protein-GST Fusion can be found at ProteinsShort Description:
Catalog Number: B2024057 (20 ug)Weight:
0.15Length:
2Width:
0.5Height:
0.5
